✦ LIBER ✦

Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)

✍ Scribed by Julie Q. Hang; Yu Li; Yanli Yang; Nick Cammack; Tara Mirzadegan; Klaus Klumpp

Book ID: 116293958
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 665 KB
Volume: 352
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2006.11.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and Anti-HIV-1 Activity Evalua

Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or α-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.

✍ Ji, Lei; Chen, Fen-Er; De Clercq, Erik; Balzarini, Jan; Pannecouque, Christophe 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 8 KB

Synthesis and Anti-HIV-1 Activity Evalua

✍ Ji, Lei; Chen, Fen-Er; De Clercq, Erik; Balzarini, Jan; Pannecouque, Christophe 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 209 KB

Non-Nucleoside HIV-1 Reverse-Transcripta

Non-Nucleoside HIV-1 Reverse-Transcriptase Inhibitors. Part 10 : Synthesis and Anti-HIV Activity of 5-Alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a Mono- or Disubstituted 2-Amino Function as Novel ‘Dihydro-Alkoxy-Benzyl-Oxopyrimidine’ (DABO) Analogues

✍ Yueping Wang; Fen-Er Chen; Jan Balzarini; Erik De Clercq; Christophe Pannecouque 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

60 Inhibition of wild type and mutant HI

60 Inhibition of wild type and mutant HIV reverse transcriptases by a new class of non-nucleoside reverse transcriptase inhibitors: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg2, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, A. S. Cantrell3, S. R. Jaskunas3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 57 KB

71 SAR studies optimizing HIV-1 inhibiti

71 SAR studies optimizing HIV-1 inhibiting activities of LY73497, a new series of non-nucleoside inhibitors of reverse transcriptase: P. Engelhardt1, M. Hoberg1, J. Kangametsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, L. Vrang1, H. Zhang1, B. Oberg1, N. G. Johansson1, F. W. Bell2, A. S. Cantrell2, J. A. Palkowitz2, S. R. Jaskunas2, C. L. Jordan2, M. D. Kinnick2, J. M. Morin, Jr.2, C. A. Parrish2, P. Pranc2, R. J. Ternansky2, R. T. Vasileff2, and S. J. West2. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 62 KB